Vaxcyte Inc
NASDAQ:PCVX

Watchlist Manager
Vaxcyte Inc Logo
Vaxcyte Inc
NASDAQ:PCVX
Watchlist
Price: 46.97 USD -1.43% Market Closed
Market Cap: 6.1B USD

Relative Value

There is not enough data to reliably calculate the relative value of PCVX.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

PCVX Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
7.9
vs History
vs Industry
Median 3Y
-16
Median 5Y
-14.9
Industry
23.7
Forward
-8.3
vs History
vs Industry
Median 3Y
-19.3
Median 5Y
-18.7
Industry
22
vs History
vs Industry
Median 3Y
-16.8
Median 5Y
-16.1
Industry
24.3
vs History
84
vs Industry
33
Median 3Y
3.5
Median 5Y
3.7
Industry
3.3
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
8.2
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
10.2
vs History
vs Industry
Median 3Y
-11.7
Median 5Y
-10.7
Industry
6.1
Forward
-5.1
vs History
vs Industry
Median 3Y
-11.6
Median 5Y
-10.6
Industry
6.5
Forward
-4.9
vs History
vs Industry
Median 3Y
-15.3
Median 5Y
-15.1
Industry
7.9
vs History
vs Industry
Median 3Y
-13.5
Median 5Y
-12.9
Industry
6.3
vs History
76
vs Industry
32
Median 3Y
11.4
Median 5Y
15
Industry
5.7

Multiples Across Competitors

PCVX Competitors Multiples
Vaxcyte Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Vaxcyte Inc
NASDAQ:PCVX
6.1B USD 0 -9.3 -5.4 -5.4
FR
Pharnext SCA
OTC:PNEXF
6T USD 33 702 776.3 -160 184.3 -194 514.8 -192 295.2
US
Abbvie Inc
NYSE:ABBV
406.5B USD 6.8 173.1 16.7 23.7
US
Amgen Inc
NASDAQ:AMGN
179.1B USD 5 25.6 18.4 18.4
US
Gilead Sciences Inc
NASDAQ:GILD
154.9B USD 5.3 19.1 12.8 12.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
117.6B USD 10 32 23.5 24.5
US
Epizyme Inc
F:EPE
94.1B EUR 2 090.3 -533.4 -580.8 -565.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
82.7B USD 5.8 18.1 17.3 19.6
AU
CSL Ltd
ASX:CSL
83B AUD 3.6 18.6 12.6 15.7
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
52.8B USD 16.4 1 211.8 163.4 198.2
NL
argenx SE
XBRU:ARGX
44B EUR 14.4 33.7 58.2 59.8
P/S Multiple
Revenue Growth P/S to Growth
US
Vaxcyte Inc
NASDAQ:PCVX
Average P/S: 3 370 493.4
Not Available
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
33 702 776.3
N/A N/A
US
Abbvie Inc
NYSE:ABBV
6.8
9%
0.8
US
Amgen Inc
NASDAQ:AMGN
5
5%
1
US
Gilead Sciences Inc
NASDAQ:GILD
5.3
4%
1.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
10
10%
1
US
E
Epizyme Inc
F:EPE
2 090.3
N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
5.8
6%
1
AU
CSL Ltd
ASX:CSL
3.6
5%
0.7
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
16.4
46%
0.4
NL
argenx SE
XBRU:ARGX
14.4
49%
0.3
P/E Multiple
Earnings Growth PEG
US
Vaxcyte Inc
NASDAQ:PCVX
Average P/E: 191.5
Negative Multiple: -9.3
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -160 184.3 N/A N/A
US
Abbvie Inc
NYSE:ABBV
173.1
89%
1.9
US
Amgen Inc
NASDAQ:AMGN
25.6
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
19.1
190%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
32
N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -533.4 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18.1
10%
1.8
AU
CSL Ltd
ASX:CSL
18.6
11%
1.7
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
1 211.8
N/A N/A
NL
argenx SE
XBRU:ARGX
33.7
40%
0.8
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Vaxcyte Inc
NASDAQ:PCVX
Average EV/EBITDA: 40.4
Negative Multiple: -5.4
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -194 514.8 N/A N/A
US
Abbvie Inc
NYSE:ABBV
16.7
14%
1.2
US
Amgen Inc
NASDAQ:AMGN
18.4
11%
1.7
US
Gilead Sciences Inc
NASDAQ:GILD
12.8
7%
1.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
23.5
16%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -580.8 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.3
11%
1.6
AU
CSL Ltd
ASX:CSL
12.6
8%
1.6
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
163.4
N/A N/A
NL
argenx SE
XBRU:ARGX
58.2
810%
0.1
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Vaxcyte Inc
NASDAQ:PCVX
Average EV/EBIT: 46.6
Negative Multiple: -5.4
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -192 295.2 N/A N/A
US
Abbvie Inc
NYSE:ABBV
23.7
30%
0.8
US
Amgen Inc
NASDAQ:AMGN
18.4
20%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
12.8
12%
1.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24.5
16%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -565.3 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
19.6
13%
1.5
AU
CSL Ltd
ASX:CSL
15.7
11%
1.4
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
198.2
N/A N/A
NL
argenx SE
XBRU:ARGX
59.8
N/A N/A